Elicio Therapeutics, Inc.
ELTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001601485
No open-market purchases or sales by Elicio Therapeutics, Inc. insiders were filed in the last 90 days; 48 institutions reported holding it in 13F filings for Q2 2026, worth $15.3M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Elicio Therapeutics, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −13 vs. Q1 2023
- Shares held
- 285.8K
- −161.5K (−36.1%) vs. Q1 2023Converted for a 1-for-10 split
- Total value
- $2.71M
- +$150.2K (+5.9%) vs. Q1 2023
- New holders
- 3
- 3 more added
- Sold out
- 16
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 48 | $15.3M |
| Q1 2026 | 47 | $28.2M |
| Q4 2025 | 37 | $16.6M |
| Q3 2025 | 28 | $20.9M |
| Q2 2025 | 21 | $11.2M |
| Q1 2025 | 24 | $9.80M |
| Q4 2024 | 17 | $2.25M |
| Q3 2024 | 18 | $2.48M |
| Q2 2024 | 20 | $2.68M |
| Q1 2024 | 18 | $3.08M |
| Q4 2023 | 18 | $2.78M |
| Q3 2023 | 18 | $2.80M |
| Q2 2023 | 15 | $2.71M |
| Q1 2023 | 28 | $2.56M |
| Q4 2022 | 30 | $3.98M |
| Q3 2022 | 38 | $4.71M |
| Q2 2022 | 43 | $5.90M |
| Q1 2022 | 47 | $13.8M |
| Q4 2021 | 53 | $20.3M |
| Q3 2021 | 47 | $69.3M |
| Q2 2021 | 41 | $66.5M |
| Q1 2021 | 41 | $92.0M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Elicio Therapeutics, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 94,939 | $901.9K | 0.11% | −3,335−3.4% | ReducedConverted for a 1-for-10 split |
| Vanguard Group Inc | 70,750 | $672.1K | 0.00% | +6,347+9.9% | AddedConverted for a 1-for-10 split |
| CM Management, LLC | 65,000 | $618.0K | 0.60% | −15,000−18.8% | ReducedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 24,169 | $229.6K | 0.00% | +7,429+44.4% | AddedConverted for a 1-for-10 split |
| Meyer Handelman Co | 13,238 | $125.8K | 0.01% | +13,238 | New |
| Bridgeway Capital Management, LLC | 12,500 | $118.8K | 0.00% | −5,000−28.6% | ReducedConverted for a 1-for-10 split |
| Bank of America Corp | 1,585 | $15.1K | 0.00% | −1,529−49.1% | ReducedConverted for a 1-for-10 split |
| Steward Partners Investment Advisory, LLC | 1,554 | $14.8K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| UBS Group AG | 645 | $6.13K | 0.00% | −804−55.5% | ReducedConverted for a 1-for-10 split |
| Citigroup Inc | 374 | $3.55K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Northwest Capital Management Inc | 350 | $3.33K | 0.00% | +350 | New |
| CWM, LLC | 350 | $3.00K | 0.00% | +350 | New |
| Tower Research Capital LLC (TRC) | 169 | $1.61K | 0.00% | −452−72.8% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 127 | $1.21K | 0.00% | −285−69.2% | ReducedConverted for a 1-for-10 split |
| Wells Fargo & Company | 15 | $143 | 0.00% | +0+1.4% | AddedConverted for a 1-for-10 split |
| BVF Inc | 0 | $0 | 0.00% | −107,130−100.0% | Sold outConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −9,302−100.0% | Sold outConverted for a 1-for-10 split |
| Millennium Management LLC | 0 | $0 | 0.00% | −6,937−100.0% | Sold outConverted for a 1-for-10 split |
| Raymond James & Associates | 0 | $0 | 0.00% | −6,000−100.0% | Sold outConverted for a 1-for-10 split |
| BlackRock Inc. | 0 | $0 | 0.00% | −5,705−100.0% | Sold outConverted for a 1-for-10 split |
| Birchview Capital, LP | 0 | $0 | 0.00% | −5,439−100.0% | Sold outConverted for a 1-for-10 split |
| Cannell Capital LLC | 0 | $0 | 0.00% | −4,018−100.0% | Sold outConverted for a 1-for-10 split |
| Valeo Financial Advisors, LLC | 0 | $0 | 0.00% | −3,695−100.0% | Sold outConverted for a 1-for-10 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −3,379−100.0% | Sold outConverted for a 1-for-10 split |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −2,450−100.0% | Sold outConverted for a 1-for-10 split |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,380−100.0% | Sold outConverted for a 1-for-10 split |
| Prudential Financial Inc | 0 | $0 | 0.00% | −1,660−100.0% | Sold outConverted for a 1-for-10 split |
| CAPROCK Group, Inc. | 0 | $0 | 0.00% | −1,573−100.0% | Sold outConverted for a 1-for-10 split |
| BLB&B Advisors, LLC | 0 | $0 | 0.00% | −1,550−100.0% | Sold outConverted for a 1-for-10 split |
| State Street Corp | 0 | $0 | 0.00% | −1,270−100.0% | Sold outConverted for a 1-for-10 split |
| Barclays PLC | 0 | $0 | 0.00% | −362−100.0% | Sold outConverted for a 1-for-10 split |